Career development program

描述：(申请者的描述摘自申请书第560页)CDC将利用更多的机会招募少数族裔科学家，利用诸如NIH少数族裔代表不足的研究补充计划和NIH少数族裔教师研究发展计划等计划。候选人将根据他们的培训、出版记录、推荐信和个人面试来选择。如上文所述，将特别重视招募妇女和少数群体。作为疾病预防控制中心的联合主席，汉密尔顿博士将负责监督获奖者的进展情况。汉密尔顿博士在培训从事卵巢癌研究的科学家方面拥有丰富的经验。在fccc，他曾指导过研究生、博士后研究员、助理研究员和访问科学家。在来到fccc之前，汉密尔顿博士在NCI指导肿瘤医学研究员和客座科学家。他在世界各地有10多名学员从事学术研究工作。最近的一位是史蒂夫·约翰逊博士，他于1998年加入宾夕法尼亚大学药理学系。每个获奖者将有一位特定的导师，他是卵巢孢子赠款中经同行审查的研究人员。导师将定期与获奖者会面，以提供指导并审查研究项目的状况。导师还将确保获奖者免受临床和行政责任的保护。汉密尔顿博士还将每季度与获奖者和导师见面，回顾科学进展。疾病预防控制中心还将负责评估职业发展奖获得者的进展情况。这将以获奖者的年度书面报告的形式，以及导师和汉密尔顿博士的评估，描述获奖者成为卵巢癌独立研究人员的进展。此外，每位获奖者每年将在卵巢孢子研究人员的月会上发表一次研讨会。

DESCRIPTION: (Applicant's Description abstracted from page 560 of the application) CDC will utilize additional opportunities to recruit minority scientists utilizing programs such as the NIH Research Supplements for Underrepresented Minorities Program and the NIH Research Development Program for Minority Faculty. Candidates will be selected on the basis of their training, publication record, and letters of recommendation as well as a personal interview. Specific emphasis will be placed on recruiting women and minorities as described. Dr. Hamilton, as co-chair of the CDC, will have responsibility for monitoring the progress of awardees. Dr. Hamilton has had extensive experience in training scientists for careers in ovarian cancer research. At FCCC, he has supervised graduate students, postdoctoral fellows, research associates, and visiting scientists. Prior to coming to FCCC, Dr. Hamilton supervised medical oncology fellows and visiting scientists at the NCI. He has more than 10 trainees pursuing academic research careers throughout the world. The most recent is Steve Johnson, Ph.D., who joined the Department of Pharmacology at the University of Pennsylvania in 1998. Each awardee will have a specific mentor who is a peer-reviewed funded investigator in the Ovarian SPORE grant. The mentor will meet regularly with the awardee to provide guidance and review the status of the research project. The mentor will also ensure that the awardee is protected from clinical and administrative responsibilities. Dr. Hamilton will meet with the awardees and mentors on a quarterly basis to review scientific progress as well. The CDC will also be responsible for evaluating the progress of the Career Development awardees. This will be in the form of a yearly written report from the awardee as well as an evaluation from the mentor and from Dr. Hamilton describing the awardee's progress towards becoming an independent researcher in ovarian cancer. In addition, each awardee will yearly present a seminar at the monthly meeting of the Ovarian SPORE investigators.